Media Summary: For over 30 years, our mission has been to use the power of science to bring new medicines to patients…over and over again. The FDA granted emergency use authorization for the treatment back in November. WebMD's Chief Medical Officer, John Whyte, MD, speaks with George Yancopoulos, MD, PhD, President & Chief Scientific Officer, ...

How Does Regeneron S Monoclonal - Detailed Analysis & Overview

For over 30 years, our mission has been to use the power of science to bring new medicines to patients…over and over again. The FDA granted emergency use authorization for the treatment back in November. WebMD's Chief Medical Officer, John Whyte, MD, speaks with George Yancopoulos, MD, PhD, President & Chief Scientific Officer, ... CNBC's Meg Tirrell joins 'The News with Shepard Smith' to discuss the The FDA approved it back in November as an emergency use drug for mild to moderate COVID-19 cases or for those who are ... CNBC's Meg Tirrell joins 'Closing Bell' to report details on the

Photo Gallery

Regeneron’s Mission
How does Regeneron's monoclonal antibody treatment work?
What Is Regeneron COVID-19 Monoclonal Antibody Treatment?
Regeneron Co-Founder on Monoclonal Antibody Treatment
Regeneron's antibody drug reduces risk of death in some Covid patients
What is the Regeneron 'cocktail?'
Regeneron CEO on how antibody cocktail may protect against Covid-19
Regeneron antibody treatment reduces risk of death in hospitalized Covid patients: Study
What Is Regeneron COVID-19 Monoclonal Antibody Treatment?
CNBC's Meg Tirrell explains Regeneron's antibody cocktail
Regeneron's Antibody Drug Helps Prevent COVID-19 For Up To 8 Months, Company Trial Results Show
Regeneron CEO on FDA request for expanded EUA of Covid antibody drug
Sponsored
Sponsored
View Detailed Profile
Regeneron’s Mission

Regeneron’s Mission

For over 30 years, our mission has been to use the power of science to bring new medicines to patients…over and over again.

How does Regeneron's monoclonal antibody treatment work?

How does Regeneron's monoclonal antibody treatment work?

The FDA granted emergency use authorization for the treatment back in November.

Sponsored
What Is Regeneron COVID-19 Monoclonal Antibody Treatment?

What Is Regeneron COVID-19 Monoclonal Antibody Treatment?

As

Regeneron Co-Founder on Monoclonal Antibody Treatment

Regeneron Co-Founder on Monoclonal Antibody Treatment

WebMD's Chief Medical Officer, John Whyte, MD, speaks with George Yancopoulos, MD, PhD, President & Chief Scientific Officer, ...

Regeneron's antibody drug reduces risk of death in some Covid patients

Regeneron's antibody drug reduces risk of death in some Covid patients

CNBC's Meg Tirrell joins 'The News with Shepard Smith' to discuss the

Sponsored
What is the Regeneron 'cocktail?'

What is the Regeneron 'cocktail?'

The FDA approved it back in November as an emergency use drug for mild to moderate COVID-19 cases or for those who are ...

Regeneron CEO on how antibody cocktail may protect against Covid-19

Regeneron CEO on how antibody cocktail may protect against Covid-19

Regeneron

Regeneron antibody treatment reduces risk of death in hospitalized Covid patients: Study

Regeneron antibody treatment reduces risk of death in hospitalized Covid patients: Study

An antibody combination made by

What Is Regeneron COVID-19 Monoclonal Antibody Treatment?

What Is Regeneron COVID-19 Monoclonal Antibody Treatment?

As

CNBC's Meg Tirrell explains Regeneron's antibody cocktail

CNBC's Meg Tirrell explains Regeneron's antibody cocktail

CNBC's Meg Tirrell joins 'Closing Bell' to report details on the

Regeneron's Antibody Drug Helps Prevent COVID-19 For Up To 8 Months, Company Trial Results Show

Regeneron's Antibody Drug Helps Prevent COVID-19 For Up To 8 Months, Company Trial Results Show

A single

Regeneron CEO on FDA request for expanded EUA of Covid antibody drug

Regeneron CEO on FDA request for expanded EUA of Covid antibody drug

Regeneron

Daily Covid-19 Minute: Regeneron’s Antibody Cocktail

Daily Covid-19 Minute: Regeneron’s Antibody Cocktail

Drug maker